Kocharian Sh M, Kocharian A M, Meliksetian G O, Akopian Zh I
Genetika. 1982;18(6):906-15.
Two pathways of adenine utilization are only known in Escherichia coli K-12: the conversion to adenosine monophosphate by adenine phosphoribosyltransferase (apt gene) and ribosylation to adenine nucleosides by purine nucleoside phosphorylase (deoD gene). The purine auxotrophs defective in synthesis of inosine monophosphate de novo (pur) and carrying apt and deoD mutations cannot satisfy their purine requirements by exogenously supplied adenine or adenosine. We have selected spontaneously secondary-site revertants (designated adu) of pur apt deoD mutants, by plating on adenine or adenosine as the sole purine source. The adu mutations frequency was 6-10(-7). The phenotypical suppression of adenine phosphoribosyltransferase and purine nucleoside phosphorylase deficiency by adu mutations is neither the consequence of apt + or deoD + reversions nor the result of appearance in mutant cells of any activity converting adenine to adenosine monophosphate or adenosine. Adenine utilization in adu mutants is not caused by constitutive synthesis or genetic modification of the substrate specificity of adenosine deaminase (add gene). The direct deamination of adenine to give hypoxanthine in extracts of adu2 mutant has been shown. The data obtained suggest the possibility of a new adenine deaminase activity to appear in E. coli by means of single mutations.
在大肠杆菌K-12中,已知腺嘌呤利用的两条途径:通过腺嘌呤磷酸核糖基转移酶(apt基因)转化为单磷酸腺苷,以及通过嘌呤核苷磷酸化酶(deoD基因)将腺嘌呤核糖基化生成腺嘌呤核苷。从头合成肌苷单磷酸(pur)有缺陷且携带apt和deoD突变的嘌呤营养缺陷型菌株,无法通过外源供应的腺嘌呤或腺苷来满足其嘌呤需求。我们通过将pur apt deoD突变体接种在腺嘌呤或腺苷作为唯一嘌呤源的平板上,筛选出了自发的二次位点回复突变体(命名为adu)。adu突变频率为6-10(-7)。adu突变对腺嘌呤磷酸核糖基转移酶和嘌呤核苷磷酸化酶缺陷的表型抑制,既不是apt +或deoD +回复的结果,也不是突变细胞中出现任何将腺嘌呤转化为单磷酸腺苷或腺苷的活性的结果。adu突变体中的腺嘌呤利用不是由腺苷脱氨酶(add基因)的组成型合成或底物特异性的基因修饰引起的。已证明adu2突变体提取物中腺嘌呤直接脱氨生成次黄嘌呤。所获得的数据表明,通过单突变在大肠杆菌中可能出现一种新的腺嘌呤脱氨酶活性。